Development of the roadmap and guidelines for the prevention and management of high blood pressure in Africa: Proceedings of the PASCAR Hypertension Task Force meeting: Nairobi, Kenya, 27 October 2014.
Africa has one of the fastest growing economies in the world. The economic changes are associated with a health transition characterised by a rise in cardiovascular risk factors and complications, which tend to affect the African population at their age of maximum productivity. Recent data from Africa have highlighted the increasing importance of high blood pressure in this region of the world. This condition is largely underdiagnosed and poorly treated, and therefore leads to stroke, renal and heart failure, and death. Henceforth, African countries are taking steps to develop relevant policies and programmes to address the issue of blood pressure and other cardiovascular risk factors in response to a call by the World Health Organisation (WHO) to reduce premature deaths from non-communicable diseases (NCDs) by 25% by the year 2025 (25 × 25). The World Heart Federation (WHF) has developed a roadmap for global implementation of the prevention and management of raised blood pressure using a health system approach to help realise the 25 × 25 goal set by the WHO. As the leading continental organisation of cardiovascular professionals, the Pan-African Society of Cardiology (PASCAR) aims to contextualise the roadmap framework of the WHF to the African continent through the PASCAR Taskforce on Hypertension. The Taskforce held a workshop in Kenya on 27 October 2014 to discuss a process by which effective prevention and control of hypertension in Africa may be achieved. It was agreed that a set of clinical guidelines for the management of hypertension are needed in Africa. The ultimate goal of this work is to develop a roadmap for implementation of the prevention and management of hypertension in Africa under the auspices of the WHF.
Douala General Hospital and Buea Faculty of Health Sciences, Douala, Cameroon. aitdzudie@yahoo.com.
A
A
Dzudie
Department of Medicine, Faculty of Health Sciences, University of Abuja/Cardiology Unit, Department of Medicince, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.
D
D
Ojji
Department of Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria.
B C
BC
Anisiuba
Le Dantec University Teaching Hospital, Dakar, Senegal.
B A
BA
Abdou
Knowledge Translation Unit, University of Cape Town Lung Institute and Department of Medicine, University of Cape Town, Cape Town, South Africa.
R
R
Cornick
Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
A
A
Damasceno
Faculty of Medicine, University of Dakar, Senegal.
A L
AL
Kane
Instituto Nacional de Saude (National Health Institute, Mozambique) and University Eduardo Mondlane, Maputo, Mozambique.
A O
AO
Mocumbi
Division of Cardiology, University of Khartoum, Sudan.
A
A
Mohamed
Executive officer, PASCAR.
G
G
Nel
Department of Clinical Medicine and Therapeutics, University of Nairobi, Kenya.
E
E
Ogola
Department of Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria.
B
B
Onwubere
Section of Cardiology, Department of Medicine, Aga Khan University Hospital, Nairobi, Kenya.
H
H
Otieno
Division of Nephrology and Hypertension, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
B
B
Rainer
Hypertension in Africa Research Team (HART); MRC Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.
A
A
Schutte
Cardiovascular Department, Faculty of Medical Sciences, University Abdou Moumouni, Niamey, Niger.
I T
IT
Ali
College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda and African Society of Hypertension (AfSoH) Initiative.
M
M
Twagirumukiza
International Centre for Circulatory Health, Imperial College, London, UK [Prof Poulter is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at the Imperial College Healthcare, NHS Trust and Imperial College London. The views expressed are those of the author and not necessarily those of the NHS, the NIHR or the Department of Health].
N
N
Poulter
Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
B
B
Mayosi
D002309:Cardiology; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D007630:Kenya; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014944:World Health Organization